Treatment with a cytotoxic agent for a malignant disease | SOP Information, SOPs and Supporting Information – alphabetic listing, C to D, Deep Vein Thrombosis G022, Rulebase for deep vein thrombosis

You are here

Treatment with a cytotoxic agent for a malignant disease

Document

Deep vein thrombosis - Treatment with a cytotoxic agent for a malignant disease Factor

Last reviewed for CCPS 22 December 2008.

Preliminary questions [21473]

21474 there is some evidence that being treated with a cytotoxic agent for a malignant disease may be a factor in the development of the condition under consideration.

21475 the veteran has been treated with a cytotoxic agent for a malignant disease at some time.

21476the malignant disease for which the veteran was treated with a cytotoxic agent is an illness or injury which is identifiable. [Default true]

21244 for the identified illness or injury, a malignant disease, the veteran was treated with a cytotoxic agent within the 90 days before the clinical onset of the condition under consideration.

25107the veteran has established the causal connection between being treated with a cytotoxic agent for a malignant disease and VEA service for the clinical onset of deep vein thrombosis.

21369the veteran has established the causal connection between being treated with a cytotoxic agent for a malignant disease and operational service for the clinical onset of deep vein thrombosis.

or

21370the veteran has established the causal connection between being treated with a cytotoxic agent for a malignant disease and eligible service for the clinical onset of deep vein thrombosis.

Clinical onset and operational service [21369]

21371the identified illness or injury, a malignant disease, is causally related to operational service.

Clinical onset and eligible service [21370]

21372the identified illness or injury, a malignant disease, is causally related to eligible service.